Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RECEPTOR OCCUPANCY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 391 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Oosthuizen, P; Emsley, RA
      First-episode psychosis: lessons from 15 years of research

      PRIMARY CARE PSYCHIATRY
    2. Gimenez-Roldan, S; Mateo, D; Navarro, E; Gines, MM
      Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis

      PARKINSONISM & RELATED DISORDERS
    3. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
      How do the atypical antipsychotics work?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    4. Tauscher, J; Kapur, S
      Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies

      CNS DRUGS
    5. Olsson, H; Farde, L
      Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulationstudy based on experimental data

      NEUROIMAGE
    6. El Yacoubi, M; Ledent, C; Parmentier, M; Ongini, E; Costentin, J; Vaugeois, JM
      In vivo labelling of the adenosine A(2A) receptor in mouse brain using theselective antagonist [H-3]SCH 58261

      EUROPEAN JOURNAL OF NEUROSCIENCE
    7. Barnes, TRE; Joyce, EM
      Antipsychotic drug treatment: recent advances

      CURRENT OPINION IN PSYCHIATRY
    8. Markianos, M; Hatzimanolis, J; Lykouras, L
      Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    9. Voruganti, L; Slomka, P; Zabel, P; Costa, G; So, A; Mattar, A; Awad, AG
      Subjective effects of AMPT-induced dopamine depletion in schizophrenia: Correlation between dysphoric responses and striatal D-2 binding ratios on SPECT imaging

      NEUROPSYCHOPHARMACOLOGY
    10. Jenkins, MK; Khoruts, A; Ingulli, E; Mueller, DL; McSorley, SJ; Reinhardt, RL; Itano, A; Pape, KA
      In vivo activation of antigen-specific CD4 T cells

      ANNUAL REVIEW OF IMMUNOLOGY
    11. Rao, ML; Hiemke, C; Grasmader, K; Baumann, P
      Olanzapine: Pharmacology, pharmacokinetics and therapeutic drug monitoring

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    12. Sa, DS; Kapur, S; Lang, AE
      Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis

      CLINICAL NEUROPHARMACOLOGY
    13. Tagawa, M; Kano, M; Okamura, N; Higuchi, M; Matsuda, M; Mizuki, Y; Arai, H; Iwata, R; Fujii, T; Komemushi, S; Ido, T; Itoh, M; Sasaki, H; Watanabe, T; Yanai, K
      Neuroimaging of histamine H-1-receptor occupancy in human brain by positron emission tomography (PET): A comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    14. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
      Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

      PSYCHONEUROENDOCRINOLOGY
    15. Yoshimura, R; Ueda, N; Nakamura, J
      Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms - Preliminary study

      NEUROPSYCHOBIOLOGY
    16. Crocker, AD; Hemsley, KM
      An animal model of extrapyramidal side effects induced by antipsychotic drugs: Relationship with D2 dopamine receptor occupancy

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    17. Sethi, KD
      Movement disorders induced by dopamine blocking agents

      SEMINARS IN NEUROLOGY
    18. Silva, JACE; Alvarez, N; Mazzotti, G; Gattaz, WF; Ospina, J; Larach, V; Starkstein, S; Oliva, D; Cousins, L; Tohen, M; Taylor, CC; Wang, J; Tran, PV
      Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    19. Lindenmayer, JP; Volavka, J; Lieberman, J; Sheitman, B; Citrome, L; Chakos, M; Czobor, P; Parker, B; Iskander, A
      Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: An open-label, prospective trial

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    20. Garcia-Anaya, M; Apiquian, R; Fresan, A
      Atypical anti-psychotics: review article.

      SALUD MENTAL
    21. Williams, R
      Optimal dosing with risperidone: Updated recommendations

      JOURNAL OF CLINICAL PSYCHIATRY
    22. Davidson, M
      Long-term safety of risperidone

      JOURNAL OF CLINICAL PSYCHIATRY
    23. Kapur, S
      Neuroimaging and drug development: An algorithm for decision making

      JOURNAL OF CLINICAL PHARMACOLOGY
    24. Kapur, S; Remington, G
      Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia

      ANNUAL REVIEW OF MEDICINE
    25. Ogata, A; Yamada, Y; Sugiura, M; Takayanagi, R; Sawada, Y; Iga, T
      Analysis of 5-HT3 receptor antagonist, ramosetron hydrochloride, based on receptor occupancy considering its active metabolite

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    26. Grunder, G; Vernaleken, I; Benkert, O
      Which properties make a neuroleptic "atypical"?

      NERVENARZT
    27. Vanasek, TL; Khoruts, A; Zell, T; Mueller, DL
      Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in theregulation of clonal anergy: Enhanced cell cycle progression promotes recall antigen responsiveness

      JOURNAL OF IMMUNOLOGY
    28. Hwang, I; Sprent, J
      Role of the actin cytoskeleton in T cell absorption and internalization ofligands from APC

      JOURNAL OF IMMUNOLOGY
    29. Alcock, SJ; Hemsley, KM; Crocker, AD
      Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy

      EUROPEAN JOURNAL OF PHARMACOLOGY
    30. Carlson, JN; Haskew, R; Wacker, J; Maisonneuve, IM; Glick, SD; Jerussi, TP
      Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite

      EUROPEAN JOURNAL OF PHARMACOLOGY
    31. Kambayashi, T; Assarsson, E; Chambers, BJ; Ljunggren, HG
      IL-2 down-regulates the expression of TCR and TCR-associated surface molecules on CD8(+) T cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    32. Bhana, N; Foster, RH; Olney, R; Plosker, GL
      Olanzapine - An updated review of its use in the management of schizophrenia

      DRUGS
    33. Bai, XF; Gao, JX; Liu, JQ; Wen, J; Zheng, P; Liu, Y
      On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen

      CANCER RESEARCH
    34. Miller, DD; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD
      Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

      BIOLOGICAL PSYCHIATRY
    35. Maurer, I; Volz, HP
      Cell-mediated side effects of psychopharmacological treatment

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    36. Talvik, M; Nordstrom, AL; Nyberg, S; Olsson, H; Halldin, C; Farde, L
      No support for regional selectivity in clozapine-treated patients: A PET study with [C-11]raclopride and [C-11]FLB 457

      AMERICAN JOURNAL OF PSYCHIATRY
    37. Lang, DJ; Kopala, LC; Vandorpe, RA; Rui, Q; Smith, GN; Goghari, VM; Honer, WG
      An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone

      AMERICAN JOURNAL OF PSYCHIATRY
    38. Meyer, JH; Wilson, AA; Ginovart, N; Goulding, V; Hussey, D; Hood, K; Houle, S
      Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: A [C-11]DASB PET imaging study

      AMERICAN JOURNAL OF PSYCHIATRY
    39. Hubl, D; Kleinlogel, H; Frohlich, L; Weinandi, T; Maurer, K; Holstein, W; Czekalla, J; Dierks, T
      Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine

      PSYCHOPHARMACOLOGY
    40. Kapur, S; Barlow, K; VanderSpek, SC; Javanmard, M; Nobrega, JN
      Drug-induced receptor occupancy: substantial differences in measurements made in vivo vs ex vivo

      PSYCHOPHARMACOLOGY
    41. de Jong, J; Hoogenboom, B; van Troostwijk, LD; de Haan, L
      Interaction of olanzapine with fluvoxamine

      PSYCHOPHARMACOLOGY
    42. Goldstein, JM
      The new generation of antipsychotic drugs: how atypical are they?

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    43. Fischman, AJ; Bonab, AA; Rubin, RH
      Regional pharmacokinetics of orally administered PET tracers

      CURRENT PHARMACEUTICAL DESIGN
    44. Ghosh, S; Ellerbroek, SM; Wu, Y; Stack, MS
      Tumor cell-mediated proteolysis: regulatory mechanisms and functional consequences

      FIBRINOLYSIS & PROTEOLYSIS
    45. Naber, D; Kasper, S
      The importance of treatment acceptability to patients

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    46. Stip, E
      Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    47. Procyshyn, RM; Kennedy, NB
      Theoretical basis for loxapine augmentation in risperidone partial responders

      CLINICAL DRUG INVESTIGATION
    48. Dean, CE
      Severe self-injurious behavior associated with treatment-resistant schizophrenia: Treatment with maintenance electroconvulsive therapy

      JOURNAL OF ECT
    49. Arimilli, S; Deshpande, S; Nag, B
      Localization of soluble major histocompatibility class II-peptide complexes on T cell surface

      MICROSCOPY RESEARCH AND TECHNIQUE
    50. Christopoulos, A; Grant, MKO; El-Fakahany, EE
      Transducer abstraction - A novel approach to the detection of partial agonist efficacy in radioligand binding studies

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    51. Oades, RD; Rao, ML; Bender, S; Sartory, G; Muller, BW
      Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D-2-receptor occupancy

      BEHAVIOURAL PHARMACOLOGY
    52. Fitzgerald, PB; Kapur, S; Caligiuri, MP; Jones, C; Silvestri, S; Remington, G; Zipursky, RB
      Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D-2 blockade

      NEUROPSYCHOPHARMACOLOGY
    53. Patat, A
      Clinical pharmacology of psychotropic drugs

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    54. Matsuo, H; Matsui, A; Nasu, R; Takanaga, H; Inoue, N; Hattori, F; Ohtani, W; Sawada, Y
      Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/pharmacodynamic study in mice

      PHARMACEUTICAL RESEARCH
    55. Kuhn, KU; Meyer, K; Maier, W
      Flupentixol - A partial atypical neuroleptic?

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    56. Kapur, S; Wadenberg, ML; Remington, G
      Are animal studies of antipsychotics appropriately dosed?: Lessons from the bedside to the bench

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    57. Chong, SA; Remington, G
      Clozapine augmentation: Safety and efficacy

      SCHIZOPHRENIA BULLETIN
    58. Brucke, T; Djamshidian, S; Bencsits, G; Pirker, W; Asenbaum, S; Podreka, I
      SPECT and PET imaging of the dopaminergic system in Parkinson's disease

      JOURNAL OF NEUROLOGY
    59. Vesely, C; Kufferle, B; Brucke, T; Kasper, S
      Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    60. Horacek, J
      Novel antipsychotics and extrapyramidal side effects. Theory and reality

      PHARMACOPSYCHIATRY
    61. Saleem, A; Aboagye, EO; Price, PM
      In vivo monitoring of drugs using radiotracer techniques

      ADVANCED DRUG DELIVERY REVIEWS
    62. Stip, E; Liddle, PF; Soucy, JP
      Need for a new framework to understand the mechanism of all antipsychotics

      JOURNAL OF CLINICAL PSYCHIATRY
    63. Remington, GJ; Kapur, S
      Need for a new framework to understand the mechanism of all antipsychotics- Reply

      JOURNAL OF CLINICAL PSYCHIATRY
    64. Glazer, WM
      Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality

      JOURNAL OF CLINICAL PSYCHIATRY
    65. David, SR; Taylor, CC; Kinon, BJ; Breier, A
      The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

      CLINICAL THERAPEUTICS
    66. Nasu, R; Matsuo, H; Takanaga, H; Ohtani, H; Sawada, Y
      Quantitative prediction of catalepsy induced by amoxapine, cinnarizine andcyclophosphamide in mice

      BIOPHARMACEUTICS & DRUG DISPOSITION
    67. Hilger, E; Kasper, S
      Properties and therapeutic use of atypical antipsychotics: a review

      WIENER KLINISCHE WOCHENSCHRIFT
    68. Manson, AJ; Schrag, A; Lees, AJ
      Low-dose olanzapine for levodopa induced dyskinesias

      NEUROLOGY
    69. Kunstler, U; Hohdorf, K; Regenthal, R; Seese, A; Gertz, HJ
      Reduction of handwriting area and D-2 dopamine receptor occupancy in therapy with typical and atypical neuroleptic drugs

      NERVENARZT
    70. Jatzko, A; Ries, S; Schreiner, A; Braus, DF
      Acute tongue and pharyngeal cramps when changing from clozapine to amisupride. A case study

      NERVENARZT
    71. Schlosser, R
      The study of neurotransmitter interactions with PET and SPECT using pharmacological challenge paradigms

      NERVENARZT
    72. Heinz, A
      Dopamine hypothesis of schizophrenia. New findings support a traditional theory

      NERVENARZT
    73. Duncan, GE; Miyamoto, S; Leipzig, JN; Lieberman, JA
      Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    74. Grimwood, S; Richards, P; Murray, F; Harrison, N; Wingrove, PB; Hutson, PH
      Characterisation of N-methyl-D-aspartate receptor-specific[H-3]ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes

      JOURNAL OF NEUROCHEMISTRY
    75. Adler, AJ; Huang, CT; Yochum, GS; Marsh, DW; Pardoll, DM
      In vivo CD4(+) T cell tolerance induction versus priming is independent ofthe rate and number of cell divisions

      JOURNAL OF IMMUNOLOGY
    76. Inomata, T; Watanabe, T; Haga, M; Hirahara, H; Abo, T; Okura, Y; Hanawa, H; Kodama, M; Izumi, T
      Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis

      JAPANESE HEART JOURNAL
    77. Murray, F; Kennedy, J; Hutson, PH; Elliot, J; Huscroft, I; Mohnen, K; Russell, MGN; Grimwood, S
      Modulation of [H-3]MK-801 binding to NMDA receptors in vivo and in vitro

      EUROPEAN JOURNAL OF PHARMACOLOGY
    78. Belzung, C; Barreau, S; Agmo, A
      Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the rat

      EUROPEAN JOURNAL OF PHARMACOLOGY
    79. Okamura, N; Yanai, K; Higuchi, M; Sakai, J; Iwata, R; Ido, T; Sasaki, H; Watanabe, T; Itoh, M
      Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine

      BRITISH JOURNAL OF PHARMACOLOGY
    80. Kapur, S; Zipursky, R; Jones, C; Remington, G; Houle, S
      Relationship between dopamine D-2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    81. Tauscher, J; Tauscher-Wisniewski, S; Kasper, S
      Treatment of patients with delirium

      AMERICAN JOURNAL OF PSYCHIATRY
    82. Bergman, J; France, CP; Holtzman, SG; Katz, JL; Koek, W; Stephens, DN
      Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABA(A)-ergic ligands

      PSYCHOPHARMACOLOGY
    83. Wadenberg, MLG; Kapur, S; Soliman, A; Jones, C; Vaccarino, F
      Dopamine D-2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

      PSYCHOPHARMACOLOGY
    84. Fitzgerald, PB; Kapur, S; Remington, G; Roy, P; Zipursky, RB
      Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels

      PSYCHOPHARMACOLOGY
    85. Nyberg, S; Farde, L
      Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies

      PSYCHOPHARMACOLOGY
    86. Bartenstein, P; Grunwald, F; Kuwert, T; Tatsch, K; Sabri, O; Benkert, O; Fahlbusch, R; Grunder, G; Herholz, K; Weiller, C
      Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma

      NUKLEARMEDIZIN-NUCLEAR MEDICINE
    87. Remington, G; Chong, SA
      Conventional versus novel antipsychotics: changing concepts and clinical implications

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    88. Perlmutter, JS; Moerlein, SM
      PET measurements of dopaminergic pathways in the brain

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    89. Aman, MG; Madrid, A
      Atypical antipsychotics in persons with developmental disabilities

      MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
    90. Kenakin, T
      The measurement of efficacy in the drug discovery agonist selection process

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    91. Kendrick, T
      The newer, 'atypical' antipsychotic drugs - their development and current therapeutic use

      BRITISH JOURNAL OF GENERAL PRACTICE
    92. Valmori, D; Fonteneau, JF; Valitutti, S; Gervois, N; Dunbar, R; Lienard, D; Rimoldi, D; Cerundolo, V; Jotereau, F; Cerottini, JC; Speiser, DE; Romero, P
      Optimal activation of tumor-reactive T cells by selected antigenic peptideanalogues

      INTERNATIONAL IMMUNOLOGY
    93. Wada, H; Ishizuka, T; Itaya, S; Yamada, K; Kajita, K; Kimura, M; Miura, A; Shibata, T; Kanoh, Y; Ishizawa, M; Yasuda, K
      Inhibitory effect of glyburide on thrombin-induced platelet aggregation and phosphoinositide metabolism in normal human platelets

      PLATELETS
    94. Kasper, S; Tauscher, J; Kufferle, B; Barnas, C; Pezawas, L; Quiner, S
      Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    95. Kasper, S; Hale, A; Azorin, JM; Moller, HJ
      Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    96. Guckel, B; Meyer, GC; Rudy, W; Batrla, R; Meuer, SC; Bastert, G; Wallwiener, D; Moebius, U
      Interleukin-12 requires initial CD80-mediated T-cell activation to supportimmune responses toward human breast and ovarian carcinoma

      CANCER GENE THERAPY
    97. Hemsley, KM; Crocker, AD
      Raclopride and chlorpromazine, but not clozapine, increase muscle rigidityin the rat: Relationship with D-2 dopamine receptor occupancy

      NEUROPSYCHOPHARMACOLOGY
    98. Breier, A; Su, TP; Malhotra, AK; Elman, I; Adler, CM; Weisenfeld, NI; Pickar, D
      Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders

      NEUROPSYCHOPHARMACOLOGY
    99. Villemagne, VL; Rothman, RB; Yokoi, F; Rice, KC; Matecka, D; Dannals, RF; Wong, DF
      Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [C-11] WIN35,428 PET scans

      SYNAPSE
    100. Hietala, J
      Ligand-receptor interactions studied by PET: implications for drug development

      ANNALS OF MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:53:57